192 related articles for article (PubMed ID: 31565099)
1. Aberrant KIF20A Expression Is Associated with Adverse Clinical Outcome and Promotes Tumor Progression in Prostate Cancer.
Zhang Z; Chai C; Shen T; Li X; Ji J; Li C; Shang Z; Niu Y
Dis Markers; 2019; 2019():4782730. PubMed ID: 31565099
[TBL] [Abstract][Full Text] [Related]
2. KIF20A Affects the Prognosis of Bladder Cancer by Promoting the Proliferation and Metastasis of Bladder Cancer Cells.
Shen T; Yang L; Zhang Z; Yu J; Dai L; Gao M; Shang Z; Niu Y
Dis Markers; 2019; 2019():4863182. PubMed ID: 31093305
[TBL] [Abstract][Full Text] [Related]
3. KIF20A Predicts Poor Survival of Patients and Promotes Colorectal Cancer Tumor Progression through the JAK/STAT3 Signaling Pathway.
Zhang Q; Di J; Ji Z; Mi A; Li Q; Du X; Wang A; Wang A; Qin C
Dis Markers; 2020; 2020():2032679. PubMed ID: 32695240
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer.
Zhang X; Wang Y; Ning Y
Urol Oncol; 2017 Mar; 35(3):111.e15-111.e23. PubMed ID: 27856181
[TBL] [Abstract][Full Text] [Related]
5. Kinesin 12 (KIF15) contributes to the development and tumorigenicity of prostate cancer.
Qureshi Z; Ahmad M; Yang WX; Tan FQ
Biochem Biophys Res Commun; 2021 Oct; 576():7-14. PubMed ID: 34474246
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Kinesin Family Member 20A Correlates with Disease Progression and Poor Prognosis in Human Nasopharyngeal Cancer: A Retrospective Analysis of 105 Patients.
Liu SL; Lin HX; Qiu F; Zhang WJ; Niu CH; Wen W; Sun XQ; Ye LP; Wu XQ; Lin CY; Song LB; Guo L
PLoS One; 2017; 12(1):e0169280. PubMed ID: 28081138
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1.
Lin ZY; Huang YQ; Zhang YQ; Han ZD; He HC; Ling XH; Fu X; Dai QS; Cai C; Chen JH; Liang YX; Jiang FN; Zhong WD; Wang F; Wu CL
Int J Cancer; 2014 Aug; 135(3):541-50. PubMed ID: 24382668
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of kinesin family member 20A is associated with unfavorable clinical outcome and tumor progression in epithelial ovarian cancer.
Li H; Zhang W; Sun X; Chen J; Li Y; Niu C; Xu B; Zhang Y
Cancer Manag Res; 2018; 10():3433-3450. PubMed ID: 30254487
[TBL] [Abstract][Full Text] [Related]
9. HMGCS2 functions as a tumor suppressor and has a prognostic impact in prostate cancer.
Wan S; Xi M; Zhao HB; Hua W; Liu YL; Zhou YL; Zhuo YJ; Liu ZZ; Cai ZD; Wan YP; Zhong WD
Pathol Res Pract; 2019 Aug; 215(8):152464. PubMed ID: 31176575
[TBL] [Abstract][Full Text] [Related]
10. CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway.
Ji J; Shen T; Li Y; Liu Y; Shang Z; Niu Y
Oncol Rep; 2021 Mar; 45(3):921-932. PubMed ID: 33650660
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of long non-coding RNA LOC400891 promotes tumor progression and poor prognosis in prostate cancer.
Wang J; Cheng G; Li X; Pan Y; Qin C; Yang H; Hua L; Wang Z
Tumour Biol; 2016 Jul; 37(7):9603-13. PubMed ID: 26797783
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of SLC6A1 associates with drug resistance and poor prognosis in prostate cancer.
Chen C; Cai Z; Zhuo Y; Xi M; Lin Z; Jiang F; Liu Z; Wan Y; Zheng Y; Li J; Zhou X; Zhu J; Zhong W
BMC Cancer; 2020 Apr; 20(1):289. PubMed ID: 32252682
[TBL] [Abstract][Full Text] [Related]
13. FOXM1 modulates docetaxel resistance in prostate cancer by regulating KIF20A.
Yu H; Xu Z; Guo M; Wang W; Zhang W; Liang S; Xu Z; Ye J; Zhu G; Zhang C; Lin J
Cancer Cell Int; 2020 Nov; 20(1):545. PubMed ID: 33292277
[TBL] [Abstract][Full Text] [Related]
14. SMC1A promotes growth and migration of prostate cancer in vitro and in vivo.
Pan XW; Gan SS; Ye JQ; Fan YH; Hong Υ; Chu CM; Gao Y; Li L; Liu X; Chen L; Huang Y; Xu H; Ren JZ; Yin L; Qu FJ; Huang H; Cui XG; Xu DF
Int J Oncol; 2016 Nov; 49(5):1963-1972. PubMed ID: 27667360
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of peroxiredoxins in prostate cancer: consistent upregulation of PRDX3 and PRDX4.
Basu A; Banerjee H; Rojas H; Martinez SR; Roy S; Jia Z; Lilly MB; De León M; Casiano CA
Prostate; 2011 May; 71(7):755-65. PubMed ID: 21031435
[TBL] [Abstract][Full Text] [Related]
16. Low expression of KIF20A suppresses cell proliferation, promotes chemosensitivity and is associated with better prognosis in HCC.
Wu C; Qi X; Qiu Z; Deng G; Zhong L
Aging (Albany NY); 2021 Sep; 13(18):22148-22163. PubMed ID: 34491228
[TBL] [Abstract][Full Text] [Related]
17. High KIFC1 expression is associated with poor prognosis in prostate cancer.
Kostecka LG; Olseen A; Kang K; Torga G; Pienta KJ; Amend SR
Med Oncol; 2021 Mar; 38(5):47. PubMed ID: 33760984
[TBL] [Abstract][Full Text] [Related]
18. The previously uncharacterized lncRNA APP promotes prostate cancer progression by acting as a competing endogenous RNA.
Shi X; Zhang W; Nian X; Lu X; Li Y; Liu F; Wang F; He B; Zhao L; Zhu Y; Ren S; Sun Y
Int J Cancer; 2020 Jan; 146(2):475-486. PubMed ID: 31107971
[TBL] [Abstract][Full Text] [Related]
19. Identification of candidate diagnostic and prognostic biomarkers for human prostate cancer: RPL22L1 and RPS21.
Liang Z; Mou Q; Pan Z; Zhang Q; Gao G; Cao Y; Gao Z; Pan Z; Feng W
Med Oncol; 2019 May; 36(6):56. PubMed ID: 31089825
[TBL] [Abstract][Full Text] [Related]
20. MTSS1 hypermethylation is associated with prostate cancer progression.
Chen J; Huang L; Zhu Q; Wang Z; Tang Z
J Cell Physiol; 2020 Mar; 235(3):2687-2697. PubMed ID: 31541465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
